Analysts from Bank of America predict a favorable environment for mergers and acquisitions in the medtech space in 2025.
Stereotaxis (STXS) and Shanghai MicroPort EP Medtech announced that the Magbot Magnetic Navigation Ablation Catheter has received regulatory ...
Corza Health founder Greg Lucier discusses growth at Corza Medical and how it competes against the world's largest device ...
After securing Medicare coverage for its wearable neurostimulator to help people control their hand tremors, Cala Health has ...
In a rapidly advancing healthcare landscape, medical technology companies are at the forefront of innovation, delivering ...
AngioDynamics received FDA 510(k) clearance for its NanoKnife System for prostate tissue ablation in intermediate-risk ...
Strategic Partnership between China MedTech Entrepreneurship Camp and EFEC ...
Knowles Corporation (NYSE: KN), a leading global supplier of high-performance electronics for demanding applications, including capacitors and radio frequency ("RF") filters, advanced medtech ...
R&D incentive uncertainty, migration changes, and the cost of living crisis are slamming the Australian startup community, ...
(688351.SH, “MicroPort EP”), today announced that the Magbot™ Magnetic Navigation Ablation Catheter has received regulatory approval from China’s National Medical Products Administration (NMPA). The ...
Arun Menawat, CEO of Profound Medical, talks about the company’s innovative TULSA-PRO technology. | Profound Medical CEO Arun Menawat discusses TULSA-PRO, an innovative technology for treating ...
Presentations included moderated posters describing the advances the company has made in developing new multimodal CPR technology ...